par de Castro, Gilberto;Awada, Ahmad 
Référence Current opinion in oncology, 18, 4, page (307-315)
Publication Publié, 2006-07
Référence Current opinion in oncology, 18, 4, page (307-315)
Publication Publié, 2006-07
Article révisé par les pairs
| Titre: |
|
| Auteur: | de Castro, Gilberto; Awada, Ahmad |
| Informations sur la publication: | Current opinion in oncology, 18, 4, page (307-315) |
| Statut de publication: | Publié, 2006-07 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Anti-angiogenic agents |
| Bortezomib | |
| Farnesyltransferase inhibitors | |
| Lenalidomide | |
| Molecular-targeted therapies | |
| Tyrosine-kinase inhibitors | |
| MeSH keywords: | Antineoplastic Agents -- adverse effects |
| Boronic Acids -- adverse effects | |
| Drug Design | |
| Farnesyltranstransferase -- antagonists & inhibitors | |
| Humans | |
| Immunologic Factors -- adverse effects | |
| Neoplasms -- therapy | |
| Protease Inhibitors -- pharmacology | |
| Proteasome Endopeptidase Complex -- metabolism | |
| Protein-Tyrosine Kinases -- antagonists & inhibitors | |
| Pyrazines -- adverse effects | |
| Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors | |
| Thalidomide -- adverse effects | |
| Thalidomide -- analogs & derivatives | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1040-8746 |
| info:doi/10.1097/01.cco.0000228733.55132.ea | |
| info:pii/00001622-200607000-00002 | |
| info:scp/33748079780 | |
| info:pmid/16721122 |
